A Study to Assess the Efficacy and Safety of RO7965032 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study will assess the safety and efficacy of RO7965032 to address a significant unmet medical need in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD)
Epistemonikos ID: edea4c6ae82f06f79450690188758437b97aed89
First added on: Oct 02, 2026